Učitavanje...
Intravitreal bevacizumab in persistent retinopathy secondary to malignant hypertension
PURPOSE: To evaluate the efficacy and safety of intravitreal bevacizumab (IVB) injection in persistent retinopathy secondary to malignant hypertension (MHT). PATIENTS AND METHODS: Single IVB injection of 1.25 mg/0.05 ml in 12 cases with persistent retinopathy secondary to MHT more than one month aft...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3729855/ https://ncbi.nlm.nih.gov/pubmed/23964183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjopt.2012.02.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|